CDAP medication shortages leave citizens struggling

Trinidad and Tobago's citizens are facing significant hardship as essential medications under the Chronic Disease Assistance Programme (CDAP) have been out of stock for months. This widespread shortage is forcing many to seek more expensive alternatives, disproportionately affecting middle and lower-income individuals.

The situation has persisted since last year, with reports indicating a lack of action to resolve the ongoing issues for those reliant on CDAP for critical medications like those for cholesterol. The program's failure to provide these basic necessities leaves patients in a precarious position, struggling to afford necessary treatments.

Questions are being raised about the potential motives behind the shortages. One possibility is that suppliers may be withholding medications from the government agency to capitalize on rising prices as demand for out-of-stock CDAP drugs grows. This practice would further exacerbate the financial burden on vulnerable populations.

The average person is now at the mercy of higher prices, forced to purchase items not available through CDAP with funds they may not have. The ongoing crisis highlights a critical failure in the public health system's ability to provide consistent access to essential medicines for its citizens.